EGFR and non-small cell lung carcinoma: In the case of non-small cell lung cancer, a PET/CT-based deep learning model served as an effective tool for determining EGFR mutational status and could serve to predict whether a patient will have a longer progression-free survival, in response to EGFR-TKIs or ICIs, based solely on imaging data [31].